BNT164b1

Phase of Development

Phase 1

Vaccine Platform

RNA vaccine

Candidate Overview

Sponsor / Lead Developer: BioNTech

Development partner(s): Bill & Melinda Gates Foundation

Clinical Trial Status: Active Trials

Target Route of Administration: Intramuscular

Clinical Trials

ACTIVE TRIALS
Registry NumberNCT05537038
Clinical Trial PhasePhase 1
Clinical Trial SponsorBioNTech SE
Primary endpoint(s) for this clinical trialSafety
Target population(s) for clinical trialAdults
_________________________
Registry NumberNCT05547464
Clinical Trial PhasePhase 1
Clinical Trial SponsorBioNTech SE
Primary endpoint(s) for this clinical trialSafety
Target population(s) for clinical trialAdults

Source: Vaccine Developer, ClinicalTrials.gov

Date Updated/Reviewed: 12-Sep-2023